Tag: abeona therapeutics

February 13, 2018

Abeona Therapeutics Receives FDA Orphan Drug Designation for ABO-202 Gene Therapy Program

Abeona Therapeutics (NASDAQ:ABEO), a leading clinical-stage biopharmaceutical company focused on developing novel cell and gene therapies for life-threatening rare genetic...
February 13, 2018

Abeona Therapeutics Receives FDA Orphan Drug Designation for ABO-202 Gene Therapy Program

Abeona Therapeutics (NASDAQ:ABEO), a leading clinical-stage biopharmaceutical company focused on developing novel cell and gene therapies for life-threatening rare genetic...
February 9, 2018

Abeona Therapeutics Reports Top-Line Data from Phase 1/2 Gene Therapy Trial in MPS IIIA

Abeona Therapeutics (NASDAQ:ABEO), a leading clinical-stage biopharmaceutical company focused on developing novel cell and gene therapies for life-threatening rare genetic...
January 29, 2018

Abeona Receives FDA Regenerative Medicine Advanced Therapy Designation

Abeona Therapeutics (NASDAQ:ABEO), a leading clinical-stage biopharmaceutical company focused on developing novel cell and gene therapies for life-threatening rare genetic...
August 29, 2017

Abeona Therapeutics Receives FDA Breakthrough Therapy Designation

Abeona Therapeutics announced the US Food and Drug Administration granted a Breakthrough Therapy designation status to the company's EB-101 gene...
August 16, 2017

Abeona Therapeutics Expands ABO-102 Gene Therapy Clinical Trials

Abeona Therapeutics announced an expansion to its gene therapy clinical trials for patients with MPS IIIA in the US, Europe,...
August 15, 2017

Abeona Therapeutics Reports Q2 Financial Results

Abeona Therapeutics shared their financial results for the second quarter of 2017 and provided a business update to shareholders.